Transcenta Holding has announced that its wholly-owned subsidiary, HJB, has signed an exclusive agreement with Eli Lilly...
The Department of Mechanical Engineering of The Hong Kong Polytechnic University (PolyU) has recently developed an elect...
Romaco China will open a processing laboratory for solid pharmaceuticals on the Truking campus in Changsha right on time...
RegeneRx Biopharmaceuticals, a clinical-stage drug development company focused on tissue protection, repair and regenera...
STA Pharmaceutical Co., Ltd., (WuXi STA) - a subsidiary of WuXi AppTec - announces that its new drug product m...
Medtronic plc, the global leader in medical technology, has announced the launch of the Medtronic MedTech Innovation Acc...
Global health service company Cigna Corporation has released the results of its 2019 Cigna 360 Well-Being Survey - ...
WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for bio...
HitGen has announced that the company has entered into a research collaboration with Almirall to identify novel small mo...
Huakang Biomedical Holdings Company Limited, a medical device group specialised in the research and development, manufac...
Sosei Group Corporation confirms that Ultibro® Breezhaler® and Seebri® Breezhaler® have been launched by...
Researchers from Xi'an Jiaotong-Liverpool University have completed a high-resolution prediction of the whole-transcript...
To accelerate the development of cell and gene therapy, ATLATL centre and Miltenyi Biotec have cooperated...
WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...
MilliporeSigma signs a non-binding Memorandum of Understanding with GenScript for a strategic alliance fo...
Shineco, a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized textiles, and...
Hong Kong, The HKTDC Hong Kong International Medical and Healthcare Fair (Medical Fair) will take place at the Hong Kong...
InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in Jan...
